These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 38322012)

  • 1. Association between spatial distribution of leukocyte subsets and clinical presentation of head and neck squamous cell carcinoma.
    Netzer C; von Arps-Aubert V; Mačinković I; von der Grün J; Küffer S; Ströbel P; von Knethen A; Weigert A; Beutner D
    Front Immunol; 2023; 14():1240394. PubMed ID: 38322012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer cell-specific PD-L1 expression is a predictor of poor outcome in patients with locally advanced oral cavity squamous cell carcinoma.
    Wang M; Qin L; Thia K; Nguyen T; MacDonald S; Belobrov S; Kranz S; Goode D; Trapani JA; Wiesenfeld D; Neeson PJ
    J Immunother Cancer; 2024 Oct; 12(10):. PubMed ID: 39357980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the tumor immune microenvironment in human papillomavirus-positive and -negative head and neck squamous cell carcinomas.
    Succaria F; Kvistborg P; Stein JE; Engle EL; McMiller TL; Rooper LM; Thompson E; Berger AE; van den Brekel M; Zuur CL; Haanen J; Topalian SL; Taube JM
    Cancer Immunol Immunother; 2021 May; 70(5):1227-1237. PubMed ID: 33125511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spatial Profiles of Intratumoral PD-1
    Yoshimura K; Tsujikawa T; Mitsuda J; Ogi H; Saburi S; Ohmura G; Arai A; Shibata S; Thibault G; Chang YH; Clayburgh DR; Yasukawa S; Miyagawa-Hayashino A; Konishi E; Itoh K; Coussens LM; Hirano S
    Front Immunol; 2021; 12():769534. PubMed ID: 34777389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. M1 macrophages induce PD-L1
    Wu J; Pang X; Yang X; Zhang M; Chen B; Fan H; Wang H; Yu X; Tang Y; Liang X
    J Immunother Cancer; 2023 Dec; 11(12):. PubMed ID: 38148114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Role of CD68
    Chohan MH; Perry M; Laurance-Young P; Salih VM; Foey AD
    Br J Biomed Sci; 2023; 80():11065. PubMed ID: 37397243
    [No Abstract]   [Full Text] [Related]  

  • 7. The immune microenvironment of HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma: a multiparametric quantitative and spatial analysis unveils a rationale to target treatment-naïve tumors with immune checkpoint inhibitors.
    Tosi A; Parisatto B; Menegaldo A; Spinato G; Guido M; Del Mistro A; Bussani R; Zanconati F; Tofanelli M; Tirelli G; Boscolo-Rizzo P; Rosato A
    J Exp Clin Cancer Res; 2022 Sep; 41(1):279. PubMed ID: 36123711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Personal immune profiles: Diversity and prognostic value for oral tongue squamous cell carcinoma evaluated by comprehensive immune parameter analyses with multiplex immunofluorescence.
    Daroonpan P; Ouchi R; Zhang C; Nagai S; Nishii N; Kashima Y; Tsushima F; Harada H; Hamagaki M; Ikeda T; Aida J; Kaomongkolgit R; Azuma M
    Oral Oncol; 2023 Aug; 143():106458. PubMed ID: 37329869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MHC-I and PD-L1 Expression is Associated with Decreased Tumor Outgrowth and is Radiotherapy-inducible in the Murine Head and Neck Squamous Cell Carcinoma Model MOC1.
    Boreel DF; Sandker GGW; Ansems M; van den Bijgaart RJE; Peters JPW; Span PN; Adema GJ; Heskamp S; Bussink J
    Mol Imaging Biol; 2024 Oct; 26(5):835-846. PubMed ID: 39009951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic role of tumor associated macrophages in squamous cell carcinoma of the head and neck: A systematic review and meta-analysis.
    Bisheshar SK; van der Kamp MF; de Ruiter EJ; Ruiter LN; van der Vegt B; Breimer GE; Willems SM
    Oral Oncol; 2022 Dec; 135():106227. PubMed ID: 36335818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spatial and Quantitative Analysis of Tumor-Associated Macrophages: Intratumoral CD163-/PD-L1+ TAMs as a Marker of Favorable Clinical Outcomes in Triple-Negative Breast Cancer.
    Shinohara H; Kobayashi M; Hayashi K; Nogawa D; Asakawa A; Ohata Y; Kubota K; Takahashi H; Yamada M; Tokunaga M; Kinugasa Y; Oda G; Nakagawa T; Onishi I; Kinowaki Y; Kurata M; Ohashi K; Kitagawa M; Yamamoto K
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36362023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA methylation profiles differ in responders versus non-responders to anti-PD-1 immune checkpoint inhibitors in patients with advanced and metastatic head and neck squamous cell carcinoma.
    Starzer AM; Heller G; Tomasich E; Melchardt T; Feldmann K; Hatziioannou T; Traint S; Minichsdorfer C; Schwarz-Nemec U; Nackenhorst M; Müllauer L; Preusser M; Berghoff AS; Fuereder T
    J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35338086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of programmed-death ligand in the human head and neck squamous cell carcinoma microenvironment is mediated through matrix metalloproteinase-mediated proteolytic cleavage.
    Hira-Miyazawa M; Nakamura H; Hirai M; Kobayashi Y; Kitahara H; Bou-Gharios G; Kawashiri S
    Int J Oncol; 2018 Feb; 52(2):379-388. PubMed ID: 29345283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of CD68
    Troiano G; Caponio VCA; Adipietro I; Tepedino M; Santoro R; Laino L; Lo Russo L; Cirillo N; Lo Muzio L
    Oral Oncol; 2019 Jun; 93():66-75. PubMed ID: 31109698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TLR9 Mediated Tumor-Stroma Interactions in Human Papilloma Virus (HPV)-Positive Head and Neck Squamous Cell Carcinoma Up-Regulate PD-L1 and PD-L2.
    Baruah P; Bullenkamp J; Wilson POG; Lee M; Kaski JC; Dumitriu IE
    Front Immunol; 2019; 10():1644. PubMed ID: 31379843
    [No Abstract]   [Full Text] [Related]  

  • 16. CD163
    Kubota K; Moriyama M; Furukawa S; Rafiul HASM; Maruse Y; Jinno T; Tanaka A; Ohta M; Ishiguro N; Yamauchi M; Sakamoto M; Maehara T; Hayashida JN; Kawano S; Kiyoshima T; Nakamura S
    Sci Rep; 2017 May; 7(1):1755. PubMed ID: 28496107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spatial PD-L1, immune-cell microenvironment, and genomic copy-number alteration patterns and drivers of invasive-disease transition in prospective oral precancer cohort.
    William WN; Zhang J; Zhao X; Parra ER; Uraoka N; Lin HY; Peng SA; El-Naggar AK; Rodriguez-Canales J; Song J; Gillenwater AM; Wistuba II; Myers JN; Gold KA; Ferrarotto R; Hwu P; Davoli T; Lee JJ; Heymach JV; Papadimitrakopoulou VA; Lippman SM
    Cancer; 2023 Mar; 129(5):714-727. PubMed ID: 36597662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic role of PD-L1 expression for survival in head and neck squamous cell carcinoma: A systematic review and meta-analysis.
    Yang WF; Wong MCM; Thomson PJ; Li KY; Su YX
    Oral Oncol; 2018 Nov; 86():81-90. PubMed ID: 30409325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of Intra-tumoral and Peripheral PD-1/PD-L1 Immunity in Head and Neck Cancer.
    Idel C; Ribbat-Idel J; VON Bernuth A; Fleckner J; Rades D; Kirfel J; Sailer V; Plötze-Martin K; Bruchhage KL; Pries R
    Anticancer Res; 2023 Dec; 43(12):5349-5358. PubMed ID: 38030173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and role of the immune checkpoint regulator PD-L1 in the tumor-stroma interplay of pancreatic ductal adenocarcinoma.
    Daunke T; Beckinger S; Rahn S; Krüger S; Heckl S; Schäfer H; Wesch D; Pilarsky C; Eckstein M; Hartmann A; Röcken C; Wandmacher AM; Sebens S
    Front Immunol; 2023; 14():1157397. PubMed ID: 37449210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.